Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Posts Strong Q3 Revenue Growth as Shares Jump 11 Percent

NEW YORK, Oct. 19 (GenomeWeb News) - Shares in cheminformatics company Tripos were up more than 11 percent in mid-afternoon trading today after the company announced a 16-percent gain in third-quarter revenue.

 

Total receipts for the three months ended Sept. 30 increased to $16.1 million from $13.8 million one year ago.

 

The results echoed growth across Tripos' three business sections: Year-over-year revenue from discovery informatics service grew to $6 million from 5.8 million; discovery informatics grew to $1.2 million from $759,000; and discovery research products and services grew to $8.8 million from $7.2 million.

 

Third-quarter R&D spending also increased, to $16.1 million from $13.8 million, the company said.

 

Tripos also posted a loss of $145,000, or $.02 per share, from a net gain of $964,000, or $.11 per share, for the same period one year ago.

 

Despite the red ink, shares in Tripos were up 11.4 percent, or $.42, at $4.10 in mid-afternoon trade on the Nasdaq exchange.

 

Tripos said it had around $4.8 million in cash and equivalents as of Sept. 30.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.